Incidence, risk factors, type, and management of ACS in patients with MDS. (A) The cumulative incidence of ACS in the whole cohort. (B) Distribution of cases according to type of ACS. Type I ACS include ST-elevation MI (STEMI), non–ST-elevation MI (NSTEMI), and unstable angina; whereas type II ACS include type II MI. (C) Utilization of coronary angiography for ACS. (D) Utilization of percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) for ACS. (E) Guideline-recommended pharmacotherapy utilization in patients with type I and II ACS. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blockers; DAPT, dual antiplatelet therapy.